Welcome to LookChem.com Sign In|Join Free
  • or
Pyrazinecarboxylic acid, 5-formyl-, methyl ester (9CI) is a chemical compound belonging to the pyrazinecarboxylic acid family. It is a methyl ester derivative of 5-formylpyrazine-2-carboxylic acid, characterized by a molecular formula of C7H7N3O3 and a molecular weight of 181.15 g/mol. This yellow to brown crystalline solid is soluble in organic solvents and is primarily utilized as an intermediate in the synthesis of pharmaceuticals and agrochemicals.

710322-57-9

Post Buying Request

710322-57-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

710322-57-9 Usage

Uses

Used in Pharmaceutical Industry:
Pyrazinecarboxylic acid, 5-formyl-, methyl ester (9CI) is used as a key intermediate in the synthesis of various pharmaceuticals for its potential applications in medicine. Its unique chemical structure allows for the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, Pyrazinecarboxylic acid, 5-formyl-, methyl ester (9CI) serves as an essential intermediate in the production of agrochemicals. Its role in the synthesis of various agrochemicals contributes to the development of effective pesticides and other agricultural products to enhance crop protection and yield.

Check Digit Verification of cas no

The CAS Registry Mumber 710322-57-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,1,0,3,2 and 2 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 710322-57:
(8*7)+(7*1)+(6*0)+(5*3)+(4*2)+(3*2)+(2*5)+(1*7)=109
109 % 10 = 9
So 710322-57-9 is a valid CAS Registry Number.

710322-57-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 5-formylpyrazine-2-carboxylate

1.2 Other means of identification

Product number -
Other names methyl 5-formylpyrazine-2-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:710322-57-9 SDS

710322-57-9Relevant academic research and scientific papers

Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists

Swanson, Devin M.,Shah, Chandra R.,Lord, Brian,Morton, Kirsten,Dvorak, Lisa K.,Mazur, Curt,Apodaca, Richard,Xiao, Wei,Boggs, Jamin D.,Feinstein, Mark,Wilson, Sandy J.,Barbier, Ann J.,Bonaventure, Pascal,Lovenberg, Timothy W.,Carruthers, Nicholas I.

experimental part, p. 4413 - 4425 (2009/12/24)

A series of small molecules consisting of a heterocyclic core flanked by two basic functionalities were synthesized and screened for in vitro affinity at the human histamine H3 receptor (hH3R). Nine of the twenty-eight compounds tested were found to possess a hH3R Ki of less than 5 nM and consisted of a diverse range of central hetero-aromatic linkers (pyridine, pyrazine, oxazole, isoxazole, thiazole, furan, thiophene, and pyrrole). One member of this series, (4-isopropyl-piperazin-1-yl)-(6-piperidin-1-ylmethyl-pyridin-3-yl)-methanone (37), was found to be a high affinity, selective antagonist that crosses the blood-brain barrier and occupies H3 receptors after oral administration in the rat.

Non-Imidazole heterocyclic compounds

-

Page/Page column 19-20, (2008/06/13)

Certain non-imidazole heterocyclic compounds are histamine H3 modulators useful in the treatment of histamine H3 receptor mediated diseases.

5-SUBSTITUTED-PYRAZINE OR PYRIDINE GLUCOKINASE ACTIVATORS

-

Page 140, (2010/02/07)

The present invention provides a compound according to formula (I) where the substituent designations are provided in the specification. Pharmaceutical compositions comprising a compound according to formula (I) are also provided, said compounds being glucokinase activators which are useful in the treatment of type II diabetes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 710322-57-9